AstraZeneca says COVID-19 vaccine 76% effective in new analysis, to seek U.S. approval
** AstraZeneca’s said its COVID-19 vaccine was 76% effective in a new analysis of its U.S. trial - only a tad ...
Subscribing is the best way to get our best stories immediately.